iShares U.S. Healthcare ETF (IYH) Fund Overview
Educational signal · not a buy or sell recommendation · How to read this
Beta 0.57: the stock has moved about 43% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnsweriShares U.S. Healthcare ETF (IYH) trades at $70.40. The iShares U.S. Healthcare ETF (IYH) is an exchange-traded fund designed to track the performance of U.S. healthcare equities. Sector: Financials.
Price as of · Last analyzed: Jun 14, 2026Analyst Coverage for IYH: IYH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
iShares U.S. Healthcare ETF (IYH) Financial Services Profile
iShares U.S. Healthcare ETF (IYH) offers diversified exposure to U.S. healthcare equities, including pharmaceuticals, biotechnology, and healthcare services, making it a strategic choice for investors seeking to capitalize on the growth of the healthcare sector.
What Is the Investment Thesis for IYH?
The iShares U.S. The ETF's focus on U.S. healthcare equities allows investors to capitalize on advancements in pharmaceuticals and biotechnology, which are expected to see increased funding and innovation. Furthermore, the aging population and rising healthcare expenditures are anticipated to drive demand for healthcare services, thereby benefiting the underlying companies in the ETF. With a market cap of $3.15 billion, IYH is well-positioned to leverage these growth catalysts. However, investors should remain cautious of ongoing regulatory scrutiny and potential policy changes that could impact profitability across the sector. Monitoring healthcare legislation will be critical for assessing the ETF's performance and the viability of its holdings.
Based on FMP financials and quantitative analysis
IYH Key Highlights
Market capitalization of $3.15 billion reflects significant investor interest and trust in the ETF.
- Beta of 0.57 indicates lower volatility compared to the broader market, appealing to risk-averse investors.
- Focus on U.S. healthcare equities provides exposure to a sector projected to grow at a CAGR of 7.9% through 2028.
- No dividend yield, emphasizing a strategy focused on capital appreciation rather than income generation.
- Diversified holdings across pharmaceuticals, biotechnology, and healthcare services mitigate sector-specific risks.
Who Are IYH's Competitors?
IYH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| EWC iShares MSCI Canada ETF | $58.72 | +0.75% | $5.86B | — |
| IFRA iShares U.S. Infrastructure ETF | $56.19 | +1.19% | $4.25B | — |
| BLK BlackRock, Inc. | $1059.63 | -0.44% | $164B | — |
| BX Blackstone Inc. | $111.74 | -0.45% | $135B | — |
| APOS Apollo Global Management, Inc. | $25.59 | -0.23% | $74.8B | — |
| BAM Brookfield Asset Management | $44.85 | +0.65% | $71.6B | — |
| AMP Ameriprise Financial, Inc. | $490.91 | -0.79% | $44.1B | — |
| ARES Ares Management Corporation | $117.55 | +0.84% | $38.6B | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are IYH's Key Strengths?
Strong market capitalization of $3.15 billion indicates investor confidence.
- Diversified exposure to various healthcare sectors mitigates risks.
- Managed by BlackRock, ensuring robust management and operational expertise.
What Are IYH's Weaknesses?
No dividend yield may deter income-focused investors.
- Exposure to regulatory changes that could impact healthcare profitability.
- Market volatility can affect ETF performance despite its defensive nature.
What Are the Key Risks for IYH?
Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
What Threats Does IYH Face?
- Ongoing regulatory scrutiny and potential policy changes affecting the healthcare sector.
- Economic downturns may impact investor sentiment toward equities.
- Competition from other healthcare ETFs and investment vehicles.
What Are IYH's Competitive Advantages?
- Managed by BlackRock, which has a strong reputation and extensive resources in asset management.
- Diversified holdings across multiple healthcare sub-sectors reduce exposure to individual company risks.
- The ETF's defensive nature during economic downturns attracts risk-averse investors.
What Does IYH Do?
The iShares U.S. Healthcare ETF (IYH) was launched to provide investors with a means to gain exposure to the performance of U.S. companies within the healthcare sector. It is managed by BlackRock, one of the largest asset management firms globally, which has a strong reputation for its ETFs. The fund aims to replicate the investment performance of an index that includes a diverse range of healthcare-related stocks, including those involved in pharmaceuticals, biotechnology, healthcare equipment, and healthcare services. As of now, the ETF has a market capitalization of approximately $3.15 billion, reflecting its substantial presence in the financial markets. The ETF does not pay dividends, focusing instead on capital appreciation, which aligns with the growth potential of the healthcare sector. IYH's defensive nature during economic downturns is a potential strength, as healthcare tends to remain resilient in challenging economic climates. The ETF's holdings are diversified across various sub-sectors, which helps mitigate risks associated with individual companies. As healthcare continues to evolve with advancements in technology and increasing demand for healthcare services, IYH positions itself to benefit from these trends, making it an integral part of many investors' portfolios looking to tap into the growth of the healthcare industry.
What Products and Services Does IYH Offer?
- iShares U.S. Healthcare ETF (IYH) provides investors with exposure to U.S. healthcare equities.
- The ETF mirrors the performance of a benchmark index comprised of healthcare companies.
- IYH includes stocks from various sub-sectors such as pharmaceuticals, biotechnology, and healthcare services.
- The fund is managed by BlackRock, a leading global asset management firm.
- IYH focuses on capital appreciation rather than income generation, as it does not pay dividends.
- The ETF aims to offer diversified access to the healthcare sector, minimizing individual stock risk.
How Does IYH Make Money?
- IYH generates revenue through management fees charged to investors.
- The ETF's performance is tied to the underlying healthcare equities it holds.
- IYH aims for capital appreciation by tracking the performance of a healthcare index.
- The fund's diversified approach helps mitigate risks associated with individual stock performance.
What Industry Does IYH Operate In?
The asset management industry, particularly in the context of ETFs, has seen substantial growth, with healthcare ETFs gaining traction due to the sector's resilience and growth potential. The global healthcare market is projected to reach $11.9 trillion by 2027, driven by factors such as technological advancements, an aging population, and increasing healthcare spending. The competitive landscape includes various ETFs, with IYH distinguishing itself through its focused investment strategy on U.S. healthcare equities. This positioning allows IYH to capture the growth opportunities within a sector that is increasingly vital to the economy and society.
Who Are IYH's Key Customers?
- Institutional investors seeking exposure to the healthcare sector.
- Retail investors looking for diversified investment options in healthcare.
- Financial advisors and wealth managers incorporating healthcare ETFs into client portfolios.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is an etf, not an operating company
MoonshotScore History
Recorded daily since 2026-08-23 · 41 snapshots
| 2026-08-23 | 46 |
| 2026-08-31 | 46 |
| 2026-09-08 | 46 |
| 2026-09-16 | 46 |
| 2026-09-24 | 46 |
| 2026-10-04 | 46 |
What changed?
The score has stayed at 46.
Over the same 30 days the stock moved -2.8%.
Financial Health
iShares U.S. Healthcare ETF's Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 40.92 places it in the safe zone, indicating low near-term bankruptcy risk.
IYH Financials
Bull Case vs Bear Case
Bull Case
- Strong market capitalization of $3.15 billion indicates investor confidence.
- Diversified exposure to various healthcare sectors mitigates risks.
- Managed by BlackRock, ensuring robust management and operational expertise.
Bear Case
- No dividend yield may deter income-focused investors.
- Exposure to regulatory changes that could impact healthcare profitability.
- Market volatility can affect ETF performance despite its defensive nature.
- Ongoing regulatory scrutiny and potential policy changes affecting the healthcare sector.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026
IYH Latest News
-
Exchange-Traded Funds Mixed, Equity Futures Up Pre-Bell Tuesday as Oil Prices Drop Due to Possible Diplomacy in US-Iran Conflict
MT Newswires · Sep 22, 2026
-
Exchange-Traded Funds Rise, Equity Futures up Pre-Bell Monday as Oil Prices Decline
MT Newswires · Sep 21, 2026
-
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Friday as Tech Rally Continues
MT Newswires · Sep 18, 2026
-
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Amid Economic Data, Fed Rate Hike
MT Newswires · Sep 17, 2026
IYH Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for IYH.
Price Targets
Wall Street price target analysis for IYH.
IYH MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for IYH; grades run from A+ (80-100) to F (below 30).
Latest News
Exchange-Traded Funds Mixed, Equity Futures Up Pre-Bell Tuesday as Oil Prices Drop Due to Possible Diplomacy in US-Iran Conflict
Exchange-Traded Funds Rise, Equity Futures up Pre-Bell Monday as Oil Prices Decline
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Friday as Tech Rally Continues
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Amid Economic Data, Fed Rate Hike
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.